جست‌وجوی استاد و پژوهشگر

• Adolescent substance use behaviors
• Tobacco use and cessation
• E-cigarette use patterns
• +۷ مورد دیگر

Dr. Suchitra Krishnan-Sarin is the Albert E. Kent Professor of Psychiatry at the Yale University School of Medicine and Professor of Chronic Disease Epidemiology at the Yale School of Public Health. She serves as Chair of the Human Investigations Committee (IRB) for the Human Research Protections Program and maintains extensive affiliations across Yale's research ecosystem including the Cancer Prevention and Control Program, Center for Nicotine and Tobacco Use Research at Yale (CENTURY), and Yale Tobacco Center of Regulatory Science. PhD from Purdue University (1992) Postdoctoral fellowship at Indiana University Purdue University at Indianapolis (1995) Postdoctoral Fellow at Yale University (1996) Dr. Krishnan-Sarin's research program focuses on developing a bio-behavioral understanding of substance use behaviors in adolescents and adults, with the goal of creating optimal prevention and cessation interventions. Her work spans tobacco regulatory science, adolescent vaping behaviors, and pharmacological treatments for alcohol use disorders. She examines the appeal and abuse potential of tobacco products, develops behavioral and pharmacological cessation approaches, and investigates behavioral and neural predictors of use and cessation behaviors. Her recent publications demonstrate a strong emphasis on e-cigarette flavors (particularly 'ice' components), youth vaping patterns across different demographic groups, and the development of evidence-based cessation interventions. Her work bridges basic science, clinical research, and policy implications, with numerous publications in top journals including Nicotine & Tobacco Research, Drug and Alcohol Dependence, and the Journal of the American Heart Association. Young Investigator Award from Society for Research on Nicotine and Tobacco (1997) President of Society for Research on Nicotine and Tobacco (2020-present) Dr. Krishnan-Sarin is actively involved in national tobacco regulatory efforts as Co-PI of the NIH/FDA-funded Yale Tobacco Centers Of Regulatory Science and leader of the American Heart Association-funded ENACT initiative. Her work has directly informed policy through contributions to Surgeon General's reports, service on the FDA's Tobacco Product Scientific Advisory Committee, and current membership on the CDC's Interagency Commission on Smoking and Health. She supervises a multidisciplinary research team examining youth vaping behaviors, tobacco product regulation, and intervention development. Through the Yale Tobacco Centers Of Regulatory Science and ENACT initiative, Dr. Krishnan-Sarin leads research teams investigating tobacco product use behaviors, developing cessation interventions, and informing regulatory policy. Her work brings together expertise from psychiatry, public health, neuroscience, and policy domains to address the evolving landscape of youth nicotine and substance use, with particular attention to how product design elements like flavors influence youth appeal and use patterns.

• Counselling Psychology
• Psychotherapy
• Creative Arts Therapy
• +۶ مورد دیگر

Dr. Joanna Omylinska-Thurston is an Associate Professor in Counselling and Psychotherapy at the University of Salford, School of Health & Society, and a Counselling Psychologist at the Greater Manchester Health NHS Foundation Trust (GMMH). She is the co-founder of the innovative psychotherapy approach "Arts for the Blues" developed in collaboration with Edge Hill University and the University of Salford. Her educational background includes a Professional Doctorate in Counselling Psychology, which forms the foundation of her clinical expertise and academic contributions to mental health interventions. This qualification enables her dual role in both academic and clinical settings. Dr. Omylinska-Thurston's research bridges traditional evidence-based interventions like CBT with arts psychotherapies, creating the novel "Arts for the Blues" approach that integrates drawing, writing, and movement into talking therapies for depression treatment. Her work spans depression treatment, creative arts therapy, digital psychotherapies, trauma therapy, psychological flow states, and cross-cultural studies of mental health professionals' wellbeing. She has conducted extensive research on clients' perceptions of helpful and unhelpful factors in psychological therapies, which directly informed her therapeutic innovations. Analysis of her recent publications reveals a strategic focus on building the evidence base for creative interventions through feasibility studies, realist evaluations, and systematic reviews. Her work demonstrates a methodical progression from conceptual development to implementation science, with increasing attention to scalability, cultural factors, and digital adaptation of therapeutic approaches. The cross-cultural dimension of her work, particularly studies across 12 European countries during the pandemic, adds significant depth to her contributions to the field. Her scientific recognition includes the prestigious NIHR DCAF Fellowship, which supports her current work developing a Feasibility Randomised Controlled Trial (RCT) for Arts for the Blues in NHS Talking Therapies. NIHR DCAF Fellowship Dr. Omylinska-Thurston actively supervises PhD students in Psychological Therapies and leads multiple significant research projects funded by diverse sources including GMMH, Pennine Care NHS Foundation Trust, and Arts Humanities Research Council (AHRC). Her current portfolio includes a major feasibility RCT of Arts for the Blues in NHS Talking Therapies (2024-2028), Arts for the Blues CPD training programs, and collaborative community research to tackle health inequalities through creative approaches. As a key member of the Centre for Applied Health Research at the University of Salford, she contributes to advancing knowledge in mental health interventions through interdisciplinary collaborations that bridge clinical psychology, arts practice, and healthcare delivery systems. Her work represents a significant innovation in making creative therapies accessible within mainstream NHS services while maintaining rigorous evidence standards.